Fox Business - The Power to Prosper
Search Site

Boston Scientific

Edwards Lifesciences a ‘buy’ or is there too much competition?

Belpointe Asset Management Chief Strategist David Nelson, FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes debate the outlook for Edwards Lifesciences.

Read More

  1. Investors Stick With 2013 Winners

    When it comes to picking stocks in 2014, investors appear to be sticking with 2013's winners.Listed below are the 10 stocks in the S&P 500 that rose the most last ye...

  2. Boston Scientific stents lag, CFO resigns, shares fall

    Boston Scientific Corp, which is in the midst of an attempted turnaround, reported weak sales of its heart stents and provided a disappointing fourth-quarter company...

  3. Boston Scientific to Cut 1,500 Jobs

    Boston Scientific (NYSE:BSX) announced plans on Wednesday to axe up to 1,500 positions worldwide as it looks to reduce overall costs, and it still expects to report ...

  4. Boston Scientific to pay $30 million over heart devices: U.S. Justice

    Boston Scientific Corp agreed to pay $30 million to settle allegations that the Guidant unit it acquired in 2006 knowingly sold defective heart devices implanted in ...

  5. Medical Device Makers to Discuss Cyber Threat

    Two months after drug safety regulators urged medical device manufacturers to stay alert to the risk of cyber attacks, one prominent security group said it's partner...

  6. Chesapeake Energy, Weyerhaeuser and Other Stocks Insiders Are Buying (CHK, WY)

    Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the s...

  7. Two Nifty New Dividend ETFs

    Prior to this week, roughly 60 new exchange-traded products had come to market this year.This week is brisk on the new product introduction as investors have been tr...

  8. U.S. High Court to Hear Fidelity Case to Clarify Worker Protections

    The Supreme Court said Monday that it will consider the scope of whistleblower protections written into a 2002 federal law that encourages employees at public compan...

  9. U.S. Appeals Court Reverses $593 Million Award Against J&J

    A federal appeals court Thursday overturned a $593 million patent-infringement award against Johnson & Johnson's (JNJ) Cordis subsidiary, ruling the company didn't i...

  10. Appeals Court Reverses $593 Million Award Against J&J

    A federal appeals court Thursday overturned a $593 million patent-infringement award against Johnson & Johnson's (JNJ) Cordis subsidiary, ruling the company didn't i...

  11. Plugging Hearts to Prevent Strokes Remains Area of Debate

    Mending a young person's broken heart may make for a good love story, but can it prevent strokes?That's a question the U.S. Food and Drug Administration is expected ...

  12. Edwards Lifesciences' New Heart Valve Meets Trial's Goal

    Edwards Lifesciences (EW) said a new version of its nonsurgical heart valve met its primary study goal in a late-stage trial, and that it would seek U.S. regulatory ...

  1. Americans’ net worth on the decline

    Rebalance IRA Managing Director Mitch Tuchman, Clark Howard, of ‘The Clark Howard Show,’ and ‘Steve Crowley’s American Scene’ host Steve Crowley on Americans’ declining net worth and strategies for retirement planning.

  2. Charles Payne's investment ideas making gains

    FBN’s Charles Payne, Catalyst Funds Senior Portfolio Manager David Miller and Penn Financial Group founder Matt McCall review Charles Payne’s track record so far on the show.

  3. Boston Scientific shares poised for growth?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall, FBN’s Tracy Byrnes and FOXBusiness.com reporter Kate Rogers on the outlook for Boston Scientific .

  4. Health care sector drags on the S&P

    FBN’s Liz MacDonald with an update on stocks.

  5. Making money with Boston Scientific

    FBN’s Charles Payne on Boston Scientific .

  6. Medtronic Earnings Fall on Failed Study Charges

    Medtronic Inc on Tuesday reported lower quarterly net earnings due to charges for the failed clinical study of a treatment being developed for high blood pressure.Th...

  7. Heart Devices Boost Boston Scientific Results

    Boston Scientific Corp on Tuesday reported higher fourth-quarter earnings on stronger sales of its implantable devices that manage irregular heart rhythms.The medica...

‹ Prev12345Next ›
Freebase CC-BY
Source: Boston Scientific on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL